<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37398656</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients.</ArticleTitle><Pagination><StartPage>1191083</StartPage><MedlinePgn>1191083</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1191083</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1191083</ELocationID><Abstract><AbstractText>Brain fog can be described as a constellation of new-onset neuropsychiatric sequelae in the post-acute phase of COVID-19 (long COVID). The symptoms include inattention, short-term memory loss, and reduced mental acuity, which may undermine cognition, concentration, and sleep. This cognitive impairment, persisting for weeks or months after the acute phase of SARS-CoV-2 infection, can significantly impact on daily activities and the quality of life. An important role for the complement system (C) in the pathogenesis of COVID-19 has emerged since the beginning of pandemic outbreak. A number of pathophysiological characteristics including microangiopathy and myocarditis have been attributed to dysregulated C activation due to SARS-CoV-2 infection. Mannan-binding lectin (MBL), the first recognition subcomponent of the C lectin pathway, has been shown to bind to glycosylated SARS-CoV-2 spike protein, genetic variants of <i>MBL2</i> are suggested to have an association with severe COVID-19 manifestations requiring hospitalization. In the present study, we evaluated MBL activity (lectin pathway activation) and levels in the sera of a cohort of COVID-19 patients, presenting brain fog or only hyposmia/hypogeusia as persistent symptoms, and compared them with healthy volunteers. We found significantly lower levels of MBL and lectin pathway activity in the sera of patients experiencing brain fog as compared to recovered COVID-19 patients without brain fog. Our data indicate that long COVID-associated brain fog can be listed among the variegate manifestations of increased susceptibility to infections and diseases contributed by MBL deficiency.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Bulla, Rossi, Furlanis, Agostinis, Toffoli, Balduit, Mangogna, Liccari, Morosini, Kishore and Manganotti.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bulla</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Lucrezia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Medical, Surgical and Health Sciences, Cattinara University Hospital, ASUGI, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furlanis</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Medical, Surgical and Health Sciences, Cattinara University Hospital, ASUGI, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agostinis</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toffoli</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical, Surgical and Health Science, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balduit</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangogna</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liccari</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Medical, Surgical and Health Sciences, Cattinara University Hospital, ASUGI, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morosini</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kishore</LastName><ForeName>Uday</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine, United Arab Emirates University, Al Ain, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manganotti</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Neurology Unit, Department of Medical, Surgical and Health Sciences, Cattinara University Hospital, ASUGI, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037102">Lectins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037601">Mannose-Binding Lectin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C445619">MBL2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037102" MajorTopicYN="N">Lectins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037601" MajorTopicYN="Y">Mannose-Binding Lectin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005222" MajorTopicYN="Y">Mental Fatigue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">brain fog</Keyword><Keyword MajorTopicYN="N">complement system</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">mannan-binding lectin (MBL)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>11</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37398656</ArticleId><ArticleId IdType="pmc">PMC10312368</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1191083</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19 characteristics. Biol Proced Online (2020) 22:19. doi:&#xa0;10.1186/s12575-020-00128-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12575-020-00128-2</ArticleId><ArticleId IdType="pmc">PMC7402395</ArticleId><ArticleId IdType="pubmed">32774178</ArticleId></ArticleIdList></Reference><Reference><Citation>da Rosa Mesquita R, Francelino Silva Junior LC, Santos Santana FM, Farias de Oliveira T, Campos Alc&#xe2;ntara R, Monteiro Arnozo G, et al. . Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr (2021) 133(7-8):377&#x2013;82. doi:&#xa0;10.1007/s00508-020-01760-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-020-01760-4</ArticleId><ArticleId IdType="pmc">PMC7689634</ArticleId><ArticleId IdType="pubmed">33242148</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M, Rajnik M, Aleem A, Dulebohn SC, Napoli RD. "Features, Evaluation, and Treatment of Coronavirus (COVID-19)," In StatPearls. Treasure Island (FL): StatPearls Publishing; (2023), 816.</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-S&#xe1;nchez CM, D&#xed;az-Maroto I, Fern&#xe1;ndez-D&#xed;az E, S&#xe1;nchez-Larsen &#xc1;., Layos-Romero A, Garc&#xed;a-Garc&#xed;a J, et al. . Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology (2020) 95(8):e1060&#x2013;70. doi:&#xa0;10.1212/WNL.0000000000009937</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009937</ArticleId><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol (2021) 268(9):3059&#x2013;71. doi:&#xa0;10.1007/s00415-021-10406-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10406-y</ArticleId><ArticleId IdType="pmc">PMC7826147</ArticleId><ArticleId IdType="pubmed">33486564</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ. Neurological sequelae of COVID-19. J Integr Neurosci (2022) 21(3):77. doi:&#xa0;10.31083/j.jin2103077</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.jin2103077</ArticleId><ArticleId IdType="pubmed">35633158</ArticleId></ArticleIdList></Reference><Reference><Citation>Filosto M, Cotti Piccinelli S, Gazzina S, Foresti C, Frigeni B, Servalli MC, et al. . Guillain-Barr&#xe9; Syndrome and COVID-19: a 1-year observational multicenter study. Eur J Neurol (2022) 29(11):3358&#x2013;67. doi:&#xa0;10.1111/ene.15497</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15497</ArticleId><ArticleId IdType="pmc">PMC9349567</ArticleId><ArticleId IdType="pubmed">35837806</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganotti P, Pesavento V, Buoite Stella A, Bonzi L, Campagnolo E, Bellavita G, et al. . Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2. J Neurovirol (2020) 26(4):605&#x2013;6. doi:&#xa0;10.1007/s13365-020-00858-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00858-9</ArticleId><ArticleId IdType="pmc">PMC7288617</ArticleId><ArticleId IdType="pubmed">32529516</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganotti P, Bellavita G, D'Acunto L, Tommasini V, Fabris M, Sartori A, et al. . Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barr&#xe9; syndrome and polyneuritis cranialis in COVID-19 patients: a case series. J Med Virol (2021) 93(2):766&#x2013;74. doi:&#xa0;10.1002/jmv.26289</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26289</ArticleId><ArticleId IdType="pmc">PMC7405169</ArticleId><ArticleId IdType="pubmed">32662899</ArticleId></ArticleIdList></Reference><Reference><Citation>Miners S, Kehoe PG, Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimers Res Ther (2020) 12(1):170. doi:&#xa0;10.1186/s13195-020-00744-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00744-w</ArticleId><ArticleId IdType="pmc">PMC7772800</ArticleId><ArticleId IdType="pubmed">33380345</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. . Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized covid-19 "long haulers". Ann Clin Transl Neurol (2021) 8(5):1073&#x2013;85. doi:&#xa0;10.1002/acn3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. . Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci (2022) 434:120162. doi:&#xa0;10.1016/j.jns.2022.120162</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouraeinejad A. Brain fog as a long-term sequela of COVID-19. SN Compr Clin Med (2023) 5(1):9. doi:&#xa0;10.1007/s42399-022-01352-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01352-5</ArticleId><ArticleId IdType="pmc">PMC9685075</ArticleId><ArticleId IdType="pubmed">36466122</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Maralakunte M, Garg S, Dhooria S, Sehgal I, Bhalla AS, et al. . The conundrum of 'Long-COVID-19': a narrative review. Int J Gen Med (2021) 14:2491&#x2013;506. doi:&#xa0;10.2147/IJGM.S316708</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S316708</ArticleId><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazhenets G, Schroeter N, Bormann T, Thurow J, Wagner D, Frings L, et al. . Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J Nucl Med (2021) 62(7):910&#x2013;5. doi:&#xa0;10.2967/jnumed.121.262128</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.262128</ArticleId><ArticleId IdType="pmc">PMC8882885</ArticleId><ArticleId IdType="pubmed">33789937</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, et al. . F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging (2021) 48(9):2823&#x2013;33. doi:&#xa0;10.1007/s00259-021-05215-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M, et al. . Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain (2021) 144(4):1263&#x2013;76. doi:&#xa0;10.1093/brain/awab009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchetti G, Agosta F, Canu E, Basaia S, Barbieri A, Cardamone R, et al. . Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J Neurol (2022) 269(7):3400&#x2013;12. doi:&#xa0;10.1007/s00415-022-11047-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11047-5</ArticleId><ArticleId IdType="pmc">PMC8898558</ArticleId><ArticleId IdType="pubmed">35249144</ArticleId></ArticleIdList></Reference><Reference><Citation>Aj&#x10d;evi&#x107; M, Iscra K, Furlanis G, Michelutti M, Miladinovi&#x107; A, Buoite Stella A, et al. . Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI. Sci Rep (2023) 13(1):5808. doi:&#xa0;10.1038/s41598-023-32275-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-32275-3</ArticleId><ArticleId IdType="pmc">PMC10086005</ArticleId><ArticleId IdType="pubmed">37037833</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A, Shah M, Ahmad SA, Premraj L, Wildi K, Li Bassi G, et al. . Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells (2023) 12(5):816. doi:&#xa0;10.3390/cells12050816</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050816</ArticleId><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Low RN, Low RJ, Akrami A. A review of cytokine-based pathophysiology of long COVID symptoms. Front Med (Lausanne) (2023) 10:1011936. doi:&#xa0;10.3389/fmed.2023.1011936</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Lysenkov SP, Muzhenya DV, Tuguz AR, Urakova TU, Shumilov DS, Thakushinov IA, et al. . Cholinergic deficiency in the cholinergic system as a pathogenetic link in the formation of various syndromes in COVID-19. Chin J Physiol (2023) 66(1):1&#x2013;13. doi:&#xa0;10.4103/cjop.CJOP-D-22-00072</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/cjop.CJOP-D-22-00072</ArticleId><ArticleId IdType="pubmed">36814151</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrott B, Head R, Pringle KG, Lumbers ER, Martin JH. "LONG COVID"-a hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol Res Perspect (2022) 10(1):e00911. doi:&#xa0;10.1002/prp2.911</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.911</ArticleId><ArticleId IdType="pmc">PMC8929332</ArticleId><ArticleId IdType="pubmed">35029046</ArticleId></ArticleIdList></Reference><Reference><Citation>Noris M, Benigni A, Remuzzi G. The case of complement activation in COVID-19 multiorgan impact. Kidney Int (2020) 98(2):314&#x2013;22. doi:&#xa0;10.1016/j.kint.2020.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7246017</ArticleId><ArticleId IdType="pubmed">32461141</ArticleId></ArticleIdList></Reference><Reference><Citation>Macor P, Durigutto P, Mangogna A, Bussani R, De Maso L, D'Errico S, et al. . Multiple-organ complement deposition on vascular endothelium in COVID-19 patients. Biomedicines (2021) 9(8):1003. doi:&#xa0;10.3390/biomedicines9081003</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9081003</ArticleId><ArticleId IdType="pmc">PMC8394811</ArticleId><ArticleId IdType="pubmed">34440207</ArticleId></ArticleIdList></Reference><Reference><Citation>Chouaki Benmansour N, Carvelli J, Vivier E. Complement cascade in severe forms of COVID-19: recent advances in therapy. Eur J Immunol (2021) 51(7):1652&#x2013;9. doi:&#xa0;10.1002/eji.202048959</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202048959</ArticleId><ArticleId IdType="pmc">PMC8250085</ArticleId><ArticleId IdType="pubmed">33738806</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. . Neurotoxic reactive astrocytes are induced by activated microglia. Nature (2017) 541(7638):481&#x2013;7. doi:&#xa0;10.1038/nature21029</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu LR, Liu JC, Bao JS, Bai QQ, Wang GQ. Interaction of microglia and astrocytes in the neurovascular unit. Front Immunol (2020) 11:1024. doi:&#xa0;10.3389/fimmu.2020.01024</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01024</ArticleId><ArticleId IdType="pmc">PMC7362712</ArticleId><ArticleId IdType="pubmed">32733433</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, Barres BA. Reactive astrocytes: production, function, and therapeutic potential. Immunity (2017) 46(6):957&#x2013;67. doi:&#xa0;10.1016/j.immuni.2017.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.06.006</ArticleId><ArticleId IdType="pubmed">28636962</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence JM, Schardien K, Wigdahl B, Nonnemacher MR. Roles of neuropathology-associated reactive astrocytes: a systematic review. Acta Neuropathol Commun (2023) 11(1):42. doi:&#xa0;10.1186/s40478-023-01526-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-023-01526-9</ArticleId><ArticleId IdType="pmc">PMC10009953</ArticleId><ArticleId IdType="pubmed">36915214</ArticleId></ArticleIdList></Reference><Reference><Citation>Stravalaci M, Pagani I, Paraboschi EM, Pedotti M, Doni A, Scavello F, et al. . Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. Nat Immunol (2022) 23(2):275&#x2013;86. doi:&#xa0;10.1038/s41590-021-01114-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01114-w</ArticleId><ArticleId IdType="pubmed">35102342</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, et al. . Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol (1995) 155(6):3013&#x2013;20. doi: 10.4049/jimmunol.155.6.3013</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.155.6.3013</ArticleId><ArticleId IdType="pubmed">7673719</ArticleId></ArticleIdList></Reference><Reference><Citation>Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency&#x2013;revisited. Mol Immunol (2003) 40(2-4):73&#x2013;84. doi:&#xa0;10.1016/s0161-5890(03)00104-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0161-5890(03)00104-4</ArticleId><ArticleId IdType="pubmed">12914814</ArticleId></ArticleIdList></Reference><Reference><Citation>Grumach AS, Kirschfink M. Are complement deficiencies really rare? overview on prevalence, clinical importance and modern diagnostic approach. Mol Immunol (2014) 61(2):110&#x2013;7. doi:&#xa0;10.1016/j.molimm.2014.06.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2014.06.030</ArticleId><ArticleId IdType="pubmed">25037634</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies EJ, Snowden N, Hillarby MC, Carthy D, Grennan DM, Thomson W, et al. . Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum (1995) 38(1):110&#x2013;4. doi:&#xa0;10.1002/art.1780380117</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780380117</ArticleId><ArticleId IdType="pubmed">7818559</ArticleId></ArticleIdList></Reference><Reference><Citation>Garred P, Madsen HO, Marquart H, Hansen TM, S&#xf8;rensen SF, Petersen J, et al. . Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol (2000) 27(1):26&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">10648014</ArticleId></ArticleIdList></Reference><Reference><Citation>Garred P, Str&#xf8;m JJ, Quist L, Taaning E, Madsen HO. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis (2003) 188(9):1394&#x2013;403. doi:&#xa0;10.1086/379044</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/379044</ArticleId><ArticleId IdType="pubmed">14593599</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsini F, De Blasio D, Zangari R, Zanier ER, De Simoni MG. Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis. Front Cell Neurosci (2014) 8:380. doi:&#xa0;10.3389/fncel.2014.00380</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00380</ArticleId><ArticleId IdType="pmc">PMC4224073</ArticleId><ArticleId IdType="pubmed">25426028</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelutti M, Furlanis G, Buoite Stella A, Bellavita G, Frezza N, Torresin G, et al. . Sex-dependent characteristics of neuro-Long-COVID: data from a dedicated neurology ambulatory service. J Neurol Sci (2022) 441:120355. doi:&#xa0;10.1016/j.jns.2022.120355</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120355</ArticleId><ArticleId IdType="pmc">PMC9328838</ArticleId><ArticleId IdType="pubmed">35994869</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: what do we know about "long covid"? BMJ (2020) 370:m2815. doi:&#xa0;10.1136/bmj.m2815</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2815</ArticleId><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep (2021) 11(1):16144. doi:&#xa0;10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med (2022) 28(8):1706&#x2013;14. doi:&#xa0;10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) (2021) 53(10):737&#x2013;54. doi:&#xa0;10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou MI, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Paraskevas GP, et al. . Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis (2022) 13:20406223221076890. doi:&#xa0;10.1177/20406223221076890</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan K, Lin Y, Prewitt KM, Potter DA. Multidisciplinary approach to brain fog and related persisting symptoms post COVID-19. J Health Serv Psychol (2022) 48(1):31&#x2013;8. doi:&#xa0;10.1007/s42843-022-00056-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42843-022-00056-7</ArticleId><ArticleId IdType="pmc">PMC8809226</ArticleId><ArticleId IdType="pubmed">35128461</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. . Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun (2022) 101:93&#x2013;135. doi:&#xa0;10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinzon RT, Wijaya VO, Jody AA, Nunsio PN, Buana RB. Persistent neurological manifestations in long COVID-19 syndrome: a systematic review and meta-analysis. J Infect Public Health (2022) 15(8):856&#x2013;69. doi:&#xa0;10.1016/j.jiph.2022.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.06.013</ArticleId><ArticleId IdType="pmc">PMC9221935</ArticleId><ArticleId IdType="pubmed">35785594</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB. Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. Med Sci Monit (2021) 27:e931447. doi:&#xa0;10.12659/MSM.931447</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.931447</ArticleId><ArticleId IdType="pmc">PMC7924007</ArticleId><ArticleId IdType="pubmed">33633106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocon AJ. Caught in the thickness of brain fog: exploring the cognitive symptoms of chronic fatigue syndrome. Front Physiol (2013) 4:63. doi:&#xa0;10.3389/fphys.2013.00063</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2013.00063</ArticleId><ArticleId IdType="pmc">PMC3617392</ArticleId><ArticleId IdType="pubmed">23576989</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffa RB, Duong PV, Finney J, Garber DA, Lam LM, Mathew SS, et al. . Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy? J Clin Pharm Ther (2006) 31(2):129&#x2013;38. doi:&#xa0;10.1111/j.1365-2710.2006.00726.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2710.2006.00726.x</ArticleId><ArticleId IdType="pubmed">16635046</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Stewart JM, Hatziagelaki E, Kolaitis G. Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin. Front Neurosci (2015) 9:225. doi:&#xa0;10.3389/fnins.2015.00225</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00225</ArticleId><ArticleId IdType="pmc">PMC4490655</ArticleId><ArticleId IdType="pubmed">26190965</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Dang C, Wang LH. Neuroinflammation in mild respiratory COVID-19: insights into cognitive impairment in milder cases. Mil Med Res (2022) 9(1):72. doi:&#xa0;10.1186/s40779-022-00431-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40779-022-00431-x</ArticleId><ArticleId IdType="pmc">PMC9763786</ArticleId><ArticleId IdType="pubmed">36539855</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchalla AE, Wellenius GA, Travison TG, Gagnon M, Iloputaife I, Dantoine T, et al. . Circulating vascular cell adhesion molecule-1 is associated with cerebral blood flow dysregulation, mobility impairment, and falls in older adults. Hypertension (2015) 66(2):340&#x2013;6. doi:&#xa0;10.1161/HYPERTENSIONAHA.115.05180</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.115.05180</ArticleId><ArticleId IdType="pmc">PMC4807019</ArticleId><ArticleId IdType="pubmed">26056332</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproston NR, Ashworth JJ. Role of c-reactive protein at sites of inflammation and infection. Front Immunol (2018) 9:754. doi:&#xa0;10.3389/fimmu.2018.00754</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00754</ArticleId><ArticleId IdType="pmc">PMC5908901</ArticleId><ArticleId IdType="pubmed">29706967</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. . 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax (2021) 76(4):396&#x2013;8. doi:&#xa0;10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzali B, Noris M, Lambrecht BN, Kemper C. The state of complement in COVID-19. Nat Rev Immunol (2022) 22(2):77&#x2013;84. doi:&#xa0;10.1038/s41577-021-00665-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00665-1</ArticleId><ArticleId IdType="pmc">PMC8672651</ArticleId><ArticleId IdType="pubmed">34912108</ArticleId></ArticleIdList></Reference><Reference><Citation>Agostinis C, Mangogna A, Balduit A, Aghamajidi A, Ricci G, Kishore U, et al. . COVID-19, pre-eclampsia, and complement system. Front Immunol (2021) 12:775168. doi:&#xa0;10.3389/fimmu.2021.775168</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.775168</ArticleId><ArticleId IdType="pmc">PMC8635918</ArticleId><ArticleId IdType="pubmed">34868042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballegaard V, Haugaard AK, Garred P, Nielsen SD, Munthe-Fog L. The lectin pathway of complement: advantage or disadvantage in HIV pathogenesis? Clin Immunol (2014) 154(1):13&#x2013;25. doi:&#xa0;10.1016/j.clim.2014.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2014.06.002</ArticleId><ArticleId IdType="pubmed">24928325</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown KS, Ryder SD, Irving WL, Sim RB, Hickling TP. Mannan binding lectin and viral hepatitis. Immunol Lett (2007) 108(1):34&#x2013;44. doi:&#xa0;10.1016/j.imlet.2006.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2006.10.006</ArticleId><ArticleId IdType="pubmed">17157924</ArticleId></ArticleIdList></Reference><Reference><Citation>Swale A, Miyajima F, Kolamunnage-Dona R, Roberts P, Little M, Beeching NJ, et al. . Serum mannose-binding lectin concentration, but not genotype, is associated with clostridium difficile infection recurrence: a prospective cohort study. Clin Infect Dis (2014) 59(10):1429&#x2013;36. doi:&#xa0;10.1093/cid/ciu666</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu666</ArticleId><ArticleId IdType="pmc">PMC4207421</ArticleId><ArticleId IdType="pubmed">25170052</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Gupta GS. Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs. Mol Cell Biochem (2021) 476(8):2917&#x2013;42. doi:&#xa0;10.1007/s11010-021-04107-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-021-04107-3</ArticleId><ArticleId IdType="pmc">PMC7981598</ArticleId><ArticleId IdType="pubmed">33745077</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao DN, Zhang Y, Ren YB, Kang J, Jiang L, Feng Z, et al. . Relationship of serum mannose-binding lectin levels with the development of sepsis: a meta-analysis. Inflammation (2015) 38(1):338&#x2013;47. doi:&#xa0;10.1007/s10753-014-0037-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-014-0037-5</ArticleId><ArticleId IdType="pubmed">25323207</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen F, Madsen HO, Sim RB, Koch C, Garred P. Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. J Biol Chem (2004) 279(20):21302&#x2013;11. doi:&#xa0;10.1074/jbc.M400520200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M400520200</ArticleId><ArticleId IdType="pubmed">14764589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zhou G, Zhi L, Yang H, Zhai Y, Dong X, et al. . Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis (2005) 192(8):1355&#x2013;61. doi:&#xa0;10.1086/491479</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/491479</ArticleId><ArticleId IdType="pmc">PMC7202438</ArticleId><ArticleId IdType="pubmed">16170752</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultstr&#xf6;m M, Frithiof R, Grip J, Lindel&#xf6;f L, Rooijackers O, Pigazzini S, et al. . Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Nat Immunol (2022) 23(6):861&#x2013;4. doi:&#xa0;10.1038/s41590-022-01227-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01227-w</ArticleId><ArticleId IdType="pubmed">35624204</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>